You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Managing Atopic Dermatitis in Skin of Color: A Case-Based Discussion

  • Authors: Peter Lio, MD; Neal Bhatia, MD
  • CME / ABIM MOC / CE Released: 12/28/2021
  • Valid for credit through: 12/28/2022
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, allergists and clinical immunologists, pediatricians, PCPs, NPs, and PAs involved in the treatment of patients with atopic dermatitis (AD).

The goal of this activity is to improve the diagnosis and management of moderate to severe AD in patients with skin of color (SOC).

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Diagnosing AD in patients with SOC
    • Selecting AD treatments that consider disease burden and patient concerns


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Peter Lio, MD

    Clinical Assistant Professor of Dermatology and Pediatrics
    Northwestern University Feinberg School of Medicine
    Director, Chicago Integrative Eczema Center
    Chicago, Illinois

    Disclosures

    Disclosure: Peter Lio, MD, has the following relevant financial relationships:
    Advisor or consultant for: AbbVie; Almirall; Altus Labs; AOBiome; Arbonne; Amyris; ASLAN Pharmaceuticals; Bodewell; Burt’s Bees; Concerto Biosciences; Dermavant; Eli Lilly; Exeltis; Galderma; IntraDerm; Johnson & Johnson; Kimberly-Clark; KP Away; LEO Pharmaceuticals; Level Ex; Menlo Therapeutics; Micreos; My-Or Diagnostics; Pierre Fabre; Pfizer; Realm Therapeutics; Regeneron/Sanofi Genzyme; Theraplex; Verrica; Yobee Care
    Speaker or a member of a speakers bureau for: Eli Lilly; Galderma; Incyte; LEO Pharmaceuticals; L’Oreal; Pfizer; Regeneron/Sanofi Genzyme
    Grants for clinical research from: AbbVie; AOBiome; Regeneron/Sanofi Genzyme
    Stocks, stock options, or bonds from: Altus Labs; Concerto Biosciences; KP Away; Micreos; Yobee Care
    Royalties from or patent beneficiary of: Theraplex; AIM (Theraplex Company)

  • Neal Bhatia, MD

    Director of Clinical Dermatology
    Therapeutics Clinical Research
    San Diego, California

    Disclosures

    Disclosure: Neal Bhatia, MD, has the following relevant financial relationships:
    Advisor or consultant for: AbbVie; Almirall; Biofrontera; Bristol Myers Squibb; Boehringer Ingelheim; EPI Health; Ferndale; Foamix; Galderma; Incyte; ISDIN; Johnson & Johnson; LaRoche-Posay; LEO Pharmaceuticals; Lilly; Ortho; Pfizer; Procter & Gamble; Regeneron; Sanofi; Sun Pharma; Verrica; Vyne; Vyome
    Speaker or a member of a speakers bureau for: AbbVie; Almirall; Biofrontera; Bristol Myers Squibb; BI; EPI Health; Ferndale; Foamix; Galderma; Incyte; ISDIN; Johnson & Johnson; LaRoche-Posay; LEO Pharmaceuticals; Lilly; Ortho; Pfizer; Procter & Gamble; Regeneron; Sanofi; Sun Pharma; Verrica; Vyne; Vyome
    Grants for clinical research from: AbbVie; Almirall; Biofrontera; Bristol Myers Squibb; Boehringer Ingelheim; EPI Health; Ferndale; Foamix; Galderma; Incyte; ISDIN; Johnson & Johnson; LaRoche-Posay; LEO Pharmaceuticals; Lilly; Ortho; Pfizer; Procter & Gamble; Regeneron; Sanofi; Sun Pharma; Verrica; Vyne; Vyome

Editor

  • Briana Betz, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Managing Atopic Dermatitis in Skin of Color: A Case-Based Discussion

Authors: Peter Lio, MD; Neal Bhatia, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 12/28/2021

Valid for credit through: 12/28/2022

processing....

Educational Impact Challenge

The goal of this activity is to improve the diagnosis and management of moderate to severe AD in patients with skin of color (SOC).

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.